Brookstone Capital Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.52M Buy
22,037
+7,848
+55% +$542K 0.02% 472
2025
Q1
$985K Sell
14,189
-596
-4% -$41.4K 0.01% 561
2024
Q4
$1.27M Sell
14,785
-1,623
-10% -$140K 0.02% 463
2024
Q3
$1.95M Sell
16,408
-186
-1% -$22.1K 0.03% 381
2024
Q2
$2.25M Buy
16,594
+553
+3% +$74.9K 0.04% 353
2024
Q1
$2.06M Sell
16,041
-10,452
-39% -$1.34M 0.04% 349
2023
Q4
$2.74M Buy
26,493
+12,154
+85% +$1.26M 0.05% 283
2023
Q3
$1.4M Sell
14,339
-647
-4% -$63.2K 0.03% 372
2023
Q2
$1.18M Sell
14,986
-508
-3% -$39.9K 0.02% 403
2023
Q1
$1.33M Sell
15,494
-1,114
-7% -$95.3K 0.03% 395
2022
Q4
$1.15M Buy
16,608
+958
+6% +$66.4K 0.02% 404
2022
Q3
$814K Sell
15,650
-15,976
-51% -$831K 0.02% 440
2022
Q2
$1.72M Buy
31,626
+17,104
+118% +$932K 0.04% 311
2022
Q1
$878K Sell
14,522
-552
-4% -$33.4K 0.02% 441
2021
Q4
$765K Sell
15,074
-578
-4% -$29.3K 0.01% 433
2021
Q3
$787K Sell
15,652
-322
-2% -$16.2K 0.01% 423
2021
Q2
$692K Sell
15,974
-228
-1% -$9.88K 0.01% 427
2021
Q1
$546K Buy
16,202
+388
+2% +$13.1K 0.02% 342
2020
Q4
$552K Buy
15,814
+308
+2% +$10.8K 0.02% 311
2020
Q3
$538K Sell
15,506
-532
-3% -$18.5K 0.02% 263
2020
Q2
$525K Sell
16,038
-6,324
-28% -$207K 0.03% 227
2020
Q1
$673K Sell
22,362
-594
-3% -$17.9K 0.04% 184
2019
Q4
$664K Sell
22,956
-74
-0.3% -$2.14K 0.03% 242
2019
Q3
$595K Buy
23,030
+1,348
+6% +$34.8K 0.03% 241
2019
Q2
$553K Buy
21,682
+4,708
+28% +$120K 0.03% 241
2019
Q1
$444K Buy
16,974
+2,532
+18% +$66.2K 0.03% 268
2018
Q4
$333K Buy
14,442
+1,070
+8% +$24.7K 0.03% 208
2018
Q3
$315K Buy
+13,372
New +$315K 0.02% 328
2015
Q2
Sell
-10,918
Closed -$291K 2175
2015
Q1
$291K Buy
+10,918
New +$291K 0.04% 148